Crosstree BlueBooks provide an executive review of key health sciences transactions, financial movements, and public market activity. BlueBooks also offer a glimpse of how valuations are changing and how recent trends may affect future transactions.
Transactions in the Pharma Services – Development industry totaled nine mergers & acquisitions and five financings during the month of May
In terms of M&A, the Clinical Services sector was the most active this month, with 7 M&A transactions; while in terms of financing Laboratory Services was the most active with 3 financings
Total disclosed M&A value was $2.4 million, while financing totaled $283.5 million
The largest disclosed M&A transaction this month was the $2.4 million acquisition of BASi Gaithersburg by Bioanalytical Systems, while the largest financing this month was $200 million raised by Tempus Labs
M&A and financings in the United States accounted for 67% and 60% of total transactions this month, up 11% and 20%, respectively
M&A activity this month includes acquisitions by Genstar Capital, ICON, WuXi Clinical, Caris Life Sciences and Great Point Partners
Crosstree acted as the financial advisor to Genstar on its acquisition of Advarra